Title |
Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis
|
---|---|
Published in |
Critical Care, January 2014
|
DOI | 10.1186/cc13176 |
Pubmed ID | |
Authors |
Katherine Chang, Catherine Svabek, Cristina Vazquez-Guillamet, Bryan Sato, David Rasche, Strother Wilson, Paul Robbins, Nancy Ulbrandt, JoAnn Suzich, Jonathan Green, Andriani C Patera, Wade Blair, Subramaniam Krishnan, Richard Hotchkiss |
Abstract |
A major pathophysiologic mechanism in sepsis is impaired host immunity which results in failure to eradicate invading pathogens and increased susceptibility to secondary infections. Although many immunosuppressive mechanisms exist, increased expression of the inhibitory receptor programmed cell death 1 (PD-1) and its ligand (PD-L1) are thought to play key roles. The newly recognized phenomenon of T cell exhaustion is mediated in part by PD-1 effects on T cells. This study tested the ability of anti-PD-1 and anti-PD-L1 antibodies to prevent apoptosis and improve lymphocyte function in septic patients. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | <1% |
United States | 1 | <1% |
Colombia | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 150 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 29 | 19% |
Student > Ph. D. Student | 26 | 17% |
Student > Master | 18 | 12% |
Student > Bachelor | 11 | 7% |
Student > Postgraduate | 10 | 6% |
Other | 26 | 17% |
Unknown | 34 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 44 | 29% |
Biochemistry, Genetics and Molecular Biology | 20 | 13% |
Immunology and Microbiology | 19 | 12% |
Agricultural and Biological Sciences | 19 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 3% |
Other | 12 | 8% |
Unknown | 36 | 23% |